Role of ErbB2 in the prostaglandin E 2-induced enhancement of the mitogenic response to epidermal growth factor in cultured hepatocytes

Biochemical and Biophysical Research Communications

Volumn 421, Issue 2, 2012, Pages 255-260

  Ødegård, John ^a   Aasrum, Monica ^a   Tveteraas, Ingun H ^a   Bharath, Suman P ^a   Sandnes, Dagny ^a   Christoffersen, Thoralf ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

EGF; EGFR ErbB1; ErbB2; ErbB3; Hepatocytes; PGE 2

Indexed keywords

ACTIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; LIVER CELL; MITOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DINOPROSTONE; EPIDERMAL GROWTH FACTOR; HEPATOCYTES; MAP KINASE SIGNALING SYSTEM; MITOGENS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, ERBB-2; RNA, SMALL INTERFERING; UP-REGULATION;

RATTUS;

EID: 84860426148     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.148     Document Type: Article

References (40)

1. Fausto N., Campbell J., Riehle K. Liver regeneration. Hepatology 2006, 43:S45-S53.
2. Michalopoulos G.K. Liver regeneration. J. Cell. Physiol. 2007, 213:286-300.
3. Michalopoulos G.K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 1990, 4:176-187.
4. Christoffersen T., Thoresen G.H., Dajani O.F., Melien O., Guren T.K., Refsnes M., Sandnes D. Mechanisms of hepatocyte growth regulation by hormones and growth factors. The Hepatocyte Review 2000, 209-246. Kluwer Academic Publisher, Dordrecht/Boston/London. M.N. Berry, A.M. Edwards (Eds.).
5. Jia C. Advances in the regulation of liver regeneration. Expert. Rev. Gastroenterol. Hepatol. 2011, 5:105-121.
6. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp. Cell Res. 2003, 284:31-53.
7. Sand T.E., Christoffersen T. A simple medium for the study of hepatocyte growth in culture under defined conditions. In Vitro Cell Dev. Biol. 1988, 24:981-984.
8. McGowan J.A., Strain A.J., Bucher N.L. DNA synthesis in primary cultures of adult rat hepatocytes in a defined medium: effects of epidermal growth factor, insulin, glucagon, and cyclic-AMP. J. Cell. Physiol. 1981, 108:353-363.
9. Natarajan A., Wagner B., Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. USA 2007, 104:17081-17086.
10. Holbro T., Hynes N.E. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 2004, 44:195-217.
11. Carver R.S., Stevenson M.C., Scheving L.A., Russell W.E. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology 2002, 123:2017-2027.
12. Scheving L.A., Zhang L., Stevenson M.C., Kwak E.S., Russell W.E. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G16-G25.
13. Paranjpe S., Bowen W.C., Tseng G.C., Luo J.H., Orr A., Michalopoulos G.K. RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am. J. Pathol. 2010, 176:2669-2681.
14. Sand T.E., Christoffersen T. Temporal requirement for epidermal growth factor and insulin in the stimulation of hepatocyte DNA synthesis. J. Cell. Physiol. 1987, 131:141-148.
15. MacManus J.P., Braceland B.M. A connection between the production of prostaglandins during liver regeneration and the DNA synthetic response. Prostaglandins 1976, 11:609-620.
16. Miura Y., Fukui N. Prostaglandins as possible triggers for liver regeneration after partial hepatectomy: a review. Cell. Mol. Biol. Incl. Cyto Enzymol. 1979, 25:179-184.
17. Skouteris G.G., Ord M.G., Stocken L.A. Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J. Cell. Physiol. 1988, 135:516-520.
18. Refsnes M., Thoresen G.H., Dajani O.F., Christoffersen T. Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2 alpha: additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J. Cell. Physiol. 1994, 159:35-40.
19. Dajani O.F., Meisdalen K., Guren T.K., Aasrum M., Tveteraas I.H., Lilleby P., Thoresen G.H., Sandnes D., Christoffersen T. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes. J. Cell. Physiol. 2008, 214:371-380.
20. Hashimoto N., Watanabe T., Ikeda Y., Yamada H., Taniguchi S., Mitsui H., Kurokawa K. Prostaglandins induce proliferation of rat hepatocytes through a prostaglandin E2 receptor EP3 subtype. Am. J. Physiol. 1997, 272:G597-G604.
21. Meisdalen K., Dajani O.F., Christoffersen T., Sandnes D. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors. J. Pharmacol. Exp. Ther. 2007, 322:1044-1050.
22. Nilssen L.S., Odegard J., Thoresen G.H., Molven A., Sandnes D., Christoffersen T. G protein-coupled receptor agonist-stimulated expression of ATF3/LRF-1 and c-myc and comitogenic effects in hepatocytes do not require EGF receptor transactivation. J. Cell. Physiol. 2004, 201:349-358.
23. Skouteris G.G., Kaser M.R. Prostaglandins E2 and F2a mediate the increase in c-myc expression induced by EGF in primary rat hepatocyte cultures. Biochem. Biophys. Res. Commun. 1991, 178:1240-1246.
24. Gonzalez-Espinosa C., Garcia-Sainz J.A. Hormonal modulation of c-fos expression in isolated hepatocytes. Effects of angiotensin II and phorbol myristate acetate on transcription and mRNA degradation. Biochim. Biophys. Acta 1996, 1310:217-222.
25. Sandnes D., Muller K.M., Akhtar K., Johansen E.J., Christoffersen T., Thoresen G.H. Induction of LRF-1/ATF3 by vasopressin in hepatocytes: role of MAP kinases. Cell. Physiol. Biochem. 2010, 25:523-532.
26. Scheving L.A., Stevenson M.C., Zhang X., Russell W.E. Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G322-G331.
27. Christoffersen T., Refsnes M., Bronstad G.O., Ostby E., Huse J., Haffner F., Sand T.E., Hunt N.H., Sonne O. Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone. Eur. J. Biochem. 1984, 138:217-226.
28. Sand T.E., Bronstad G., Digernes V., Killi A., Amara W., Refsnes M., Christoffersen T. Quantitative aspects of the effects of insulin, epidermal growth factor and dexamethasone on DNA synthesis in cultured adult rat hepatocytes. Acta Endocrinol. (Copenh.) 1985, 109:369-377.
29. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 2000, 25:169-193.
30. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, F. Speleman, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome. Biol. 3 (2002) RESEARCH0034.
31. Gladhaug I.P., Refsnes M., Christoffersen T. Regulation of surface expression of high-affinity receptors for epidermal growth factor (EGF) in hepatocytes by hormones, differentiating agents, and phorbol ester. Dig. Dis. Sci. 1992, 37:233-239.
32. Carver R.S., Mathew P.M., Russell W.E. Hepatic expression of ErbB3 is repressed by insulin in a pathway sensitive to PI-3 kinase inhibitors. Endocrinology 1997, 138:5195-5201.
33. Dajani O.F., Rottingen J.A., Sandnes D., Horn R.S., Refsnes M., Thoresen G.H., Iversen J.G., Christoffersen T. Growth-promoting effects of Ca(2+)-mobilizing agents in hepatocytes: lack of correlation between the acute activation of phosphoinositide-specific phospholipase C and the stimulation of DNA synthesis by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2 alpha. J. Cell. Physiol. 1996, 168:608-617.
34. Benoit V., Relic B., Leval Xd X., Chariot A., Merville M.P., Bours V. Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene 2004, 23:1631-1635.
35. Glynn S.A., Prueitt R.L., Ridnour L.A., Boersma B.J., Dorsey T.M., Wink D.A., Goodman J.E., Yfantis H.G., Lee D.H., Ambs S. COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 2010, 10:626.
36. Vadlamudi R., Mandal M., Adam L., Steinbach G., Mendelsohn J., Kumar R. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene 1999, 18:305-314.
37. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997, 16:1647-1655.
38. Olayioye M.A., Neve R.M., Lane H.A., Hynes N.E. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J. 2000, 19:3159-3167.
39. Hynes N.E., MacDonald G. ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell Biol. 2009, 21:177-184.
40. Thoresen G.H., Guren T.K., Christoffersen T. Role of ERK, p38 and PI3-kinase in EGF receptor-mediated mitogenic signalling in cultured rat hepatocytes: requirement for sustained ERK activation. Cell. Physiol. Biochem. 2003, 13:229-238.